Article
Applied Clinical Trials
Cancer Research UK Chooses Medidata Clinical Cloud
Author(s):
Cancer Research UK, a UK-based charitable funder of cancer research, has selected Medidata’s Clinical Cloud® cloud-based technology for EDC and management (Medidata Rave®) for Cancer Research UK’s Center for Drug Development (CDD)-based clinical trials at institutes, universities and hospitals across the UK.
Cancer Research UK, a UK-based charitable funder of cancer research, has selected Medidata’s Clinical Cloud® cloud-based technology for EDC and management (Medidata Rave®) for Cancer Research UK’s Center for Drug Development (CDD)-based clinical trials at institutes, universities and hospitals across the UK. By providing a standardized, central system for data entry, the Medidata platform is intended to improve data quality, allow clinicians to easily monitor patients’ safety and enable more insightful decision making across all CDD trials.
Read the full release here.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
